WHEN BIOCHEMICAL FAILURE DOES NOT MEAN CANCER RECURRENCE IN MEN TREATED BY EXTERNAL BEAM RADIOTHERAPY AND ADJUVANT HORMONES FOR INTERMEDIATE RISK PROSTATE CANCER

被引：0
|
作者：
Busca, Ionut [1 ]
Aljawi, Ghufran [1 ]
MacRae, Robert [1 ]
Eapon, Libni [1 ]
机构：
[1] Univ Ottawa, Ottawa, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 139卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
112
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [41] Early predicting factor for biochemical failure for patients with intermediate and high-risk prostate cancer treated by definitive radiotherapy.
    Kang, Hye Jin
    Kay, Chul Seung
    Yu, Mi Na
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [42] Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer
    Strom, Sara S.
    Kamat, Ashish M.
    Gruschkus, Stephen K.
    Gu, Yun
    Wen, Sijin
    Cheung, Min Rex
    Pisters, Louis L.
    Lee, Andrew K.
    Rosser, Charles J.
    Kuban, Deborah A.
    CANCER, 2006, 107 (03) : 631 - 639
  • [43] Urinary incontinence in prostate cancer patients treated with external beam radiotherapy
    Liu, M
    Pickles, T
    Berthelet, E
    Agranovich, A
    Kwan, W
    Tyldesley, S
    McKenzie, M
    Keyes, M
    Morris, J
    Pai, H
    RADIOTHERAPY AND ONCOLOGY, 2005, 74 (02) : 197 - 201
  • [44] Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer
    Zumsteg, Zachary S.
    Spratt, Daniel E.
    Romesser, Paul B.
    Pei, Xin
    Zhang, Zhigang
    Kollmeier, Marisa
    McBride, Sean
    Yamada, Yoshiya
    Zelefsky, Michael J.
    JOURNAL OF UROLOGY, 2015, 194 (06): : 1624 - 1630
  • [45] External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era
    Pollack, A
    Smith, LG
    von Eschenbach, AC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (02): : 507 - 512
  • [46] Does ADT benefit unfavourable intermediate risk prostate cancer patients treated with brachytherapy boost and external beam radiotherapy? A propensity-score matched analysis
    Mendez, Lucas C.
    Martell, Kevin
    Warner, Andrew
    Tseng, Chia-Lin
    Chung, Hans
    Loblaw, Andrew
    Rodrigues, George B.
    Morton, Gerard
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : 195 - 200
  • [47] Moderate hypofractionated external beam radiotherapy alone for intermediate risk prostate cancer: long term outcomes
    Faria, Sergio L.
    Neto, Osmar B.
    Cury, Fabio
    Shenouda, George
    Russel, Ruo
    Souhami, Luis
    CANADIAN JOURNAL OF UROLOGY, 2016, 23 (02) : 8209 - 8214
  • [48] Comparison of biochemical recurrence in prostate cancer patients treated with radical prostatectomy or radiotherapy
    Kim, Dong Soo
    Jeon, Seung Hyun
    Chang, Sung-Goo
    Lee, Sang Hyub
    KOREAN JOURNAL OF UROLOGY, 2015, 56 (10) : 703 - 709
  • [49] Hypofractionated versus conventional fractionation external beam radiotherapy in intermediate and high risk localized prostate cancer
    Samuel, Eileen
    Zaman, Saliha
    Bakar, Muhammad Abu
    Fareed, Muhammad Mohsin
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [50] Hypofractionated versus conventional fractionation external beam radiotherapy in intermediate and high risk localized prostate cancer
    Eileen Samuel
    Saliha Zaman
    Muhammad Abu Bakar
    Muhammad Mohsin Fareed
    Discover Oncology, 15
12345